Inhibitory effects of Paeonia suffruticosa Andrews extracts on VEGF binding to VEGF receptor

Natural Product Sciences

Volumn 13, Issue 2, 2007, Pages 128-131

  Lee, Sung Jin ^a   Lee, Hak Kyo ^a  

^a Hankyong National University   (South Korea)

Author keywords

Angiogenesis; Paeonia suffruticosa Andrews; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; METHANOL; PAEONIA SUFFRUTICOSA EXTRACT; PLANT EXTRACT; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; GROWTH INHIBITION; HERB; HUMAN; HUMAN CELL; KOREA; MEDICINAL PLANT; NEOVASCULARIZATION (PATHOLOGY); PAEONIA SUFFRUTICOSA; PLANT ROOT; SOLID TUMOR; TUMOR GROWTH; UMBILICAL VEIN;

EID: 34447542428     PISSN: 12263907     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Atsumi, S., Nosaka, C., Ochi, Y., Iinuma, H., and Umezawa, K., Inhibition of experimental metastasis by an α-glucosidase inhibitor, 1,6-epi-cyclophellitol. Cancer Res. 53, 4896-4899 (1993).
2. Au, T.K., Lam, T.L., Ng, T.B., Fong, W.P., and Wan, D.C., A Comparison of HIV-1 integrase inhibition by aqueous and methanol extracts of Chinese medicinal herbs. Life Science 68, 1687-1694 (2001)
3. Bae, D.G., Gho, Y.S., Yoon, W.H., and Chae, C.B., Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis, J. Biol. Chem. 275, 13588-13596 (2000).
4. Boehm-Viswanathan, T., Is angiogenesis inhibition the Holy Grail of cancer therapy? Curr. Opin. Oncol. 12, 89-94 (2000).
5. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A., Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele, Nature 380, 435-439 (1996).
6. De Vries, C.J., Escobedo, A., Ueno, H., Houck, K., Ferrara, N., and Williams, L.T., The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor, Science 255, 989-991 (1992).
7. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K.J., and Moore, M.W., Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene, Nature 380, 439-442 (1996).
8. Folkman, J., What is the evidence that tumors are angiogenesis-dependent? J. Natl. Cancer Inst. 82, 4-6 (1991).
9. Goldman, C.K., Kendall, R.I., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G.Y., Siegel, G.P., Mao, X., Bett, A.J., Huckle, W.R., Thomas, K.A., and Curiel, D.T., Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate, Proc. Natl. Acad. Sci. USA 95, 8795-8800 (1998).
10. Hsiang, C.Y., Hsieh, C.L., Wu, S.L., Lai, I.L., and Ho, T.Y., Inhibitory effect of anti-pyretic and anti-inflammatory herbs on herpes simplex virus replication. Am. J. Chin. Med. 29, 459-467 (2001).
11. Khatri, J.J., Johnson, C., Magid, R., Lessner, S.M., Laude, K.M., Dikalov, S.I., Harrison D.G., Sung H.J., Rong, Y., and Galis Z.S., Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 109, 520-525 (2004).
12. Kim, C.W., Lee, H.M., Lee, T.H., Kang, C., Kleinman, H.K., and Gho, Y.S., Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin, Cancer Res. 62, 6312-6317 (2002a).
13. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S., and Ferrara, N., Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo, Nature 362, 841-844 (1993).
14. Kim, Y.M., Hwang, S., Kim, Y.M., Pyun, B.J., Kim, T.Y., Lee, S.T., Gho, Y.S., and Kwon, Y.G., Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1, J. Biol. Chem. 277, 27872-27879 (2002b).
15. Kondo, T., Ohta, T., Igura, K., Hara, Y., and Kaji, K., Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding, Cancer Lett. 180, 139-144 (2002).
16. Lamy, S., Gingras, D., and Beliveau, R., Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation, Cancer Res. 62, 381-385 (2002).
17. Lee, S.E., Hwang, H.J., Ha, J.S., Jeong, H.S., and Kim, J.H., Screening of medicinal plant extracts for antioxidant activity. Life Sci. 73, 167-79 (2003).
18. Lee, S.J. and Ji, S.T., Inhibitory Effects of Paeonia suffruticosa extracts on maltase and Sucrase. Nat. Prod. Sci. 11, 127-130 (2005)
19. Leibovich, S.J., Polverini, P.J., Fong, T.W., Harlow, L.A., and Koch, A.E., Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA 91, 4190-4194 (1994).
20. Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V., and Frrarara, N., Vascular endothelial growth factor is a secreted angiogenic mitogen, Science 146, 1306-1309 (1989).
21. Lin, H.C., Ding, H.Y., and Wu, Y.C., Two novel compounds from Paeonia suffructicosa. J. of Nat. Prod. 61, 343-346 (1998).
22. Millauer, B., Shawver, L.K., Plate, K.H., Risau, W., and Ullrich, A., Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant, Nature 367, 576-579 (1994).
23. Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W., and Ullrich, A., High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846 (1993).
24. Ncosia, R.F., Tchao, R., and Leighton, J., Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Res. 43, 2159-2166 (1983).
25. Park, H.J. and Choi, M.Y., In vitro antiinflamatory activity of paeonol from the essential oil and its derivative methylpaeonol. Kor. J. Pharmacogn. 26, 116-120 (2005).
26. Pili, R., Cang, J., Partis, R.A., Mueller, R.A., Chrest, F.J., and Passaniti, A. The α-glucosidase inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res. 55, 2920-2926 (1995).
27. Risau, W., Angiogenic growth factors. Prog. Growth Factor Res. 2, 71-79 (1990).
28. Shalaby, F., Rossant, J., Yamaguch, T.P., Gertsenstein, M., Wu, X.F., Breitman, M.L., and Schuh, S.C., Failure of blood-island formation vasculogenesis in Flk-1-deficient mice, Nature 376, 62-66 (1995).
29. Ziche, M., Morbidelli, L., Masini, E., Amerini, S., Granger, H.J., Maggi, C.A., Geppetti, P., and Ledda, F., Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94, 2036-2044 (1994).